Adaptive Phage Therapeutics
Gaithersburg, MD
Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to beco... Read more
aphage.comCompany Details
Founded
- 2016
Employees
- Between 20 - 50 employees
Raised
- $131,684,384
Headquarters Location
- Gaithersburg, MD
Public
- No
Acquired
- Yes
Founders
- Greg MerrilCarl Merril
Company Collections
These are collections Adaptive Phage Therapeutics is a part of. Click on the collection name to view similar companies.
Adaptive Phage Therapeutics' Industries
Adaptive Phage Therapeutics Headquarters Location
Total Amount Raised: $131,684,384
Adaptive Phage Therapeutics Funding Rounds
Series B
$12,000,000
Series B Investors
AMR Action FundDeerfield Capital ManagementGrant
$5,000,000
Grant Investors
Defense Health AgencySeries B
$20,000,000
Series B Investors
AMR Action FundSeries B
$40,750,000
Series B Investors
Deerfield ManagementMayo ClinicConvertible Note
$6,175,000
Convertible Note Investors
Mayo ClinicGrant
$33,000,000
Grant Investors
Department Of DefenseSeries Unknown
$7,000,000
Series Unknown Investors
Alexandria Venture InvestmentsDebt Financing
$6,994,388
Seed
$765,000
Adaptive Phage Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Adaptive Phage Therapeutics.